(Q37969129)

26 August 2017

title

Choice of antiepileptic drugs for the elderly: possible drug interactions and adverse effects (English)

1 reference

26 August 2017

0 references

Slobodan M Jankovic

1

1 reference

26 August 2017

Milivoje Dostic

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

19 December 2011

1 reference

Expert Opinion on Drug Metabolism & Toxicology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

1

1 reference

26 August 2017

page(s)

81-91

1 reference

National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Perioperative drug therapy in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Management of new-onset epilepsy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Randomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Comparison and predictors of rash associated with 15 antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Epilepsy outcomes in elderly treated with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Review of topiramate for the treatment of epilepsy in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Safety and tolerability of oxcarbazepine in elderly patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Oxcarbazepine-induced hemolytic anemia in a geriatric patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Oxcarbazepine-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Assessment of tolerability in elderly patients: changing to lamotrigine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Cardiopulmonary arrest following intravenous phenytoin loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Fosphenytoin may cause hemodynamically unstable bradydysrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Possible heart failure exacerbation associated with pregabalin: case discussion and literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Use of antiepileptic drugs and risk of fractures: case-control study among patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Evaluation of case reports of aplastic anemia among patients treated with felbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Felbamate-associated fatal acute hepatic necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Choice of initial antiepileptic drug for older veterans: possible pharmacokinetic drug interactions with existing medications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Delirium from valproic acid with lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Neurotoxicity following addition of intravenous valproate to lamotrigine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Interaction of topiramate with carbamazepine: two case reports and a review of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

The influence of drug-drug interaction and patients' characteristics on valproic acid's clearance in adults with epilepsy using nonlinear mixed effects modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Adjunctive topiramate enhances the risk of hypothermia associated with valproic acid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Population pharmacokinetics of valproic acid concentrations in elderly nursing home residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Lack of pharmacokinetic interaction between tiagabine and erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Pharmacokinetic interaction study between eslicarbazepine acetate and lamotrigine in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Pharmacokinetic interaction study between eslicarbazepine acetate and topiramate in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Drug treatment of epilepsy in elderly people: focus on valproic Acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Pharmacokinetics of valproic acid in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Special considerations in treating the elderly patient with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Factors influencing plasma phenobarbitone levels in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Strategies for optimizing antiepileptic drug therapy in elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Population pharmacokinetics of lamotrigine in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Single and multiple dose pharmacokinetics of felbamate in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Treatment of epilepsy to optimize bone health

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Some common issues in the use of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Pharmacological and clinical aspects of antiepileptic drug use in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

Measuring the effects of antiepileptic medications on balance in older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.645535

10.1517/17425255.2012.645535

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference